Total hip arthroplasty in the treatment of severe stages of osteonecrosis of the femoral head and osteoarthritis: results and complications
- Authors: Panin M.A.1,2, Zagorodniy N.V.2,3, Boiko A.V.2, Petrosyan A.S.1
-
Affiliations:
- City Clinical Hospital N 17
- Peoples’ Friendship University of Russia
- Priorov National Medical Research Center for Traumatology and Orthopedics
- Issue: Vol 29, No 4 (2022)
- Pages: 345-353
- Section: Original study articles
- URL: https://journals.rcsi.science/0869-8678/article/view/147838
- DOI: https://doi.org/10.17816/vto109955
- ID: 147838
Cite item
Abstract
BACKGROUND: Nowadays total hip arthroplasty (THA) is the method of choice for the treatment of late stages osteonecrosis of the femoral head (OFH) and osteoarthritis (OA) of the hip joint.
OBJECTIVE: To evaluate the efficacy and complication pattern of THA in late stages of OFH and OA.
MATERIALS AND METHODS: The study included 74 patients who underwent primary THA for OA stages III–IV (Kellgren and Lawrence classification) and for OFH stages III–IV (ARCO classification). Group 1 included 34 patients with OFH stages III–IV, and group 2 — 40 patients with OA stages III–IV. The groups were comparable by gender and age. All patients underwent implantation of endoprosthesis components using press-fit fixation with a metal–polyethylene articulation. Treatment results were assessed with regard to the incidence of complications and functional results at 3, 6 months, 1 and 3 years after THA.
RESULTS: In our study, the survival rate of components after THA within 3 years after implantation was 100%. No cases of periprosthetic fracture, periprosthetic infection, and aseptic instability of endoprosthesis components were observed in both groups. The surface inflammation of the postoperative wound was detected in 1 (2.9%) patient in the OFH group and in 1 (2.5%) patient in OA group. Dislocation of the endoprosthesis occurred in 1 patient with OFH; there were no such findings in the OA group. The frequency of peri-implant osteolysis was twice lower (2.5%) in patients with OA compared to OFH group (5.8%). There were no statistically significant differences in the functional results dynamics before and after surgery between the groups (Harris score). The average Harris scale score in patients with OFH was 63 and reached 94 after 3 years; in OA group — 58 and 94, respectively.
CONCLUSION: THA is an alternative method in the treatment of severe hip arthroplasty. Endoprosthetics using a cementless endoprosthesis with a metal–polyethylene articulation demonstrated high efficacy as well as a low number of complications among patients with OFH and OA. We found no significant difference in THA results in terms of survival, postoperative complications, and functional outcome in patients with OFH and OA. Longer postoperative follow-up is advisable, which may allow us to establish some differences in treatment outcomes.
Full Text
##article.viewOnOriginalSite##About the authors
Mikhail A. Panin
City Clinical Hospital N 17; Peoples’ Friendship University of Russia
Author for correspondence.
Email: panin-mihail@yandex.ru
ORCID iD: 0000-0003-4686-7892
SPIN-code: 5834-3500
MD, Cand. Sci. (Med.), Traumatologist-Orthopedist
Russian Federation, Moscow; MoscowNikolay V. Zagorodniy
Peoples’ Friendship University of Russia; Priorov National Medical Research Center for Traumatology and Orthopedics
Email: Zagorodniy51@mail.ru
ORCID iD: 0000-0002-6736-9772
SPIN-code: 6889-8186
MD, Dr. Sci. (Med.), Professor, Corresponding member of RAS, Traumatologist-Orthopedist
Russian Federation, Moscow; MoscowAndrey V. Boiko
Peoples’ Friendship University of Russia
Email: boiko120393@gmail.com
ORCID iD: 0000-0002-7829-2045
SPIN-code: 4543-7879
Graduate Student, Traumatologist-Orthopedist
Russian Federation, MoscowArmenak S. Petrosyan
City Clinical Hospital N 17
Email: armenak.p@gmail.com
ORCID iD: 0000-0001-8837-0265
SPIN-code: 4040-1407
MD, Cand. Sci. (Med.), Traumatologist-Orthopedist
Russian Federation, MoscowReferences
- Mwale F, Wang H, Johnson AJ, et al. Abnormal vascular endothelial growth factor expression in mesenchymal stem cells from both osteonecrotic and osteoarthritic hips. Bull NYU Hosp Jt Dis. 2011;69(Suppl 1):S56–S61.
- Atik OS. Overuse and abuse of cortisone. Eklem Hastalık Cerrahisi. 2017;28(1):1. doi: 10.5606/ehc.2017.00056
- Yin J-M, Liu Z, Zhao S-C, et al. Relationship between the Apolipoprotein AI, B gene polymorphism and the risk of non-traumatic osteonecrosis. Lipids Health Dis. 2014;13(1):149. doi: 10.1186/1476-511X-13-149
- Jones KB, Seshadri T, Krantz R, et al. Cell-based therapies for osteonecrosis of the femoral head. Biology Blood Marrow Transplant. 2008;14(10):1081–1087. doi: 10.1016/j.bbmt.2008.06.017
- Yoon BH, Lee YK, Kim KC, et al. No differences in the efficacy among various core decompression modalities and non-operative treatment: a network meta-analysis. Int Orthop. 2018;42(12): 2737–2743. doi: 10.1007/s00264-018-3977-9
- Sorich MM, Cherian JJ, McElroy MJ, et al. Osteonecrosis of the hip in hematologic disease: A review of conditions and treatment options. J Long Term Eff Med Implants. 2015;25(4):253–268. doi: 10.1615/jlongtermeffmedimplants.2015012529
- Bellot F, Havet E, Gabrion A, et al. Core decompression of the femoral head for avascular necrosis. Rev Chir Orthop Reparatrice Appar Mot. 2005;91(2):114–123. (In French). doi: 10.1016/s0035-1040(05)84288-6
- Panin MA, Zagorodniy NV, Abakirov MD, et al. Core decompression of the femoral head. Literature review. N.N. Priorov Journal of Traumatology and Orthopedics. 2021;28(1):65–76. doi: 10.17816/vto59746
- Ortiguera CJ, Pulliam IT, Cabanela ME. Total hip arthroplasty for osteonecrosis: matched-pair analysis of 188 hips with long-term follow-up. J Arthroplasty. 1999;14(1):21–28. doi: 10.1016/s0883-5403(99)90197-3
- Torgashin AN, Rodionova SS, Shumsky AA, et al. Treatment of aseptic necrosis of the femoral head. Clinical guidelines. Rheumatology Science and Practice. 2020;58(6):637–645. (In Russ). doi: 10.47360/1995-4484-2020-637-645
- Issa K, Pivec R, Kapadia BH, et al. Osteonecrosis of the femoral head: the total hip replacement solution. Bone Joint J. 2013;95-B(11 Suppl. A):46–50. doi: 10.1302/0301-620X.95B11.32644
- Singh JA, Vessely MB, Harmsen WS, et al. A population-based study of trends in the use of total hip and total knee arthroplasty, 1969–2008. Mayo Clin Proc. 2010;85(10):898–904. doi: 10.4065/mcp.2010.0115
- Singh JA, Lewallen DG. Patients with osteoarthritis and avascular necrosis have better functional outcomes and those with avascular necrosis worse pain outcomes compared to rheumatoid arthritis after primary hip arthroplasty: a cohort study. BMC Med. 2013;11:210. doi: 10.1186/1741-7015-11-210
- Ng CY, Ballantyne JA, Brenkel IJ. Quality of life and functional outcome after primary total hip replacement. A five-year follow-up. J Bone Joint Surg Br. 2007;89(7):868–873. doi: 10.1302/0301-620X.89B7.18482
- Min BW, Song KS, Bae KC, et al. Second-generation cementless total hip arthroplasty in patients with osteonecrosis of the femoral head. J Arthroplasty. 2008;23(6):902–910. doi: 10.1016/j.arth.2007.07.021
- Osawa Y, Seki T, Takegami Y, et al. Cementless total hip arthroplasty for osteonecrosis and osteoarthritis produce similar results at ten years follow-up when matched for age and gender. Int Orthop. 2018;42(7):1683–1688. doi: 10.1007/s00264-018-3987-7
- Matthias J, Bostrom MP, Lane JM. A Comparison of Risks and Benefits Regarding Hip Arthroplasty Fixation. J Am Acad Orthop Surg Glob Res Rev. 2021;5(11):e21.00014. doi: 10.5435/JAAOSGlobal-D-21-00014
- Saito S, Saito M, Nishina T, et al. Long-term results of total hip arthroplasty for osteonecrosis of the femoral head. A comparison with osteoarthritis. Clin Orthop Relat Res. 1989;244:198–207.
- Ancelin D, Reina N, Cavaignac E, et al. Total hip arthroplasty survival in femoral head avascular necrosis versus primary hip osteoarthritis: case-control study with a mean 10-year follow-up after anatomical cementless metal-on-metal 28-mm replacement. Orthop Traumatol Surg Res. 2016;102(8):1029–1034. doi: 10.1016/j.otsr.2016.08.021
- Erivan R, Caputo T, Riouach H, et al. Primary total hip replacement in Ficat-Arlet stage 3 and 4 osteonecrosis: a retrospective study at a minimum 12-year follow-up. Eur J Orthop Surg Traumatol. 2020;30(5):845–850. doi: 10.1007/s00590-020-02644-z
- Han SI, Lee JH, Kim JW, et al. Long-term durability of the CLS femoral prosthesis in patients with osteonecrosis of the femoral head. J Arthroplasty. 2013;28(5):828–831. doi: 10.1016/j.arth.2012.09.017
- Radl R, Hungerford M, Materna W, et al. Higher failure rate and stem migration of an uncemented femoral component in patients with femoral head osteonecrosis than in patients with osteoarthrosis. Acta Orthop. 2005;76(1):49–55. doi: 10.1080/00016470510030319
- Qiao XF, Xue Y, Liu SC, Ji QH. Efficacy of total hip arthroplasty for the treatment of patients with femoral head avascular necrosis: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020;99(20):e20259. doi: 10.1097/MD.0000000000020259
- Betsch M, Tingart M, Driessen A, et al. Total hip replacement in avascular femoral head necrosis. Orthopade. 2018;47(9):751–756. (In German). doi: 10.1007/s00132-018-3617-5
- Odarchenko DI, Dzyuba GG, Erofeev SA, Kuznetsov NK. Problems of diagnosis and treatment of aseptic necrosis of the femoral head in contemporary traumatology and orthopedics (literature review). Genij Ortopedii. 2021;27(2):270–276. (In Russ). doi: 10.18019/1028-4427-2021-27-2-270-276
- Martynenko DV, Voloshin VP, Shevyrev KV, et al. Functional results of primary unilateral hip arthroplasty for arthrosis of the hip joint. Department of Traumatology and Orthopedics. 2020;3(41): 46–51. (In Russ). doi: 10.17238/issn2226-2016.2020.3.46-51
- Goryannaya NA, Ishekova NI, Popov VV, Bondarenko EG. Change of patients’ quality of life after hip replacement at the first stage of rehabilitation. Ekologiya cheloveka (Human Ecology). 2017;24(1):41–44. (In Russ). doi: 10.33396/1728-0869-2017-1-41-44